Drug Approval | October 18, 2023
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Lupin enters into BTA with Lupin Manufacturing Solutions
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Prateek has more than 23 years of rich experience in Human Resource
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Subscribe To Our Newsletter & Stay Updated
